Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06090253

A Hybrid Effectiveness-implementation Evaluation on Programs Promoting Healthy Aging With Sport Exercise (PHASE Program)

The goal of this clinical trial is to provide scientific evaluation on the effects of Promoting Healthy Aging with Sport Exercise (PHASE) Programs on the functional capacity of older. Based on the participants' mental well-being and physical health status, they will be provided with several tailored exercise intervention, including 1) football training; 2) gero-technology enhanced multi-component exercise; 3) slow sports and exercise; 4) walking exercise; 5) home-based exercise. A control group is also recruited and provided with no exercise intervention.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Ageing Well Behavior Motor Activity

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Hong Kong

Hong Kong

Location status: Recruiting

Location contact

Doris Sau Fung Yu, PhD

CONTACT

[email protected]

3817 6319

About this study

This clinical trial is aimed to match a range of sport exercise to older adults who are in the different phase of transition along the continuum of intrinsic capacity, and to explore effective measures to promote healthy aging. The effectiveness of the tailored interventions will be tested among the six study arms of older adults with different intrinsic capacities, with five intervention arms and one control. Exercise intensity will be measured for each participant. The outcomes are overall health status, physical function, psychological function, and cognitive function. The outcomes are measured at baseline (pre-intervention), 3 months (post-intervention), and 6 months (post-intervention) to explore the program benefits.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age above 60 years

Exclusion criteria

  • Any contraindication to exercise training

Treatment and study plan

Gerotechnology enhanced multi-component exercise

Behavioral

Intervention courses will be divided into 3 categories: Musculoskeletal training course, Neuromuscular and fall prevention training course, and cardiometabolic training course. The courses will be enabled by wearable technology, digital platform and visual display. Each of the courses will be 8 weeks in length (1 session per week), and 60 minutes per session.

Home-Based Exercise

Behavioral

The proposed elderly home gym training services will be conducted by professional fitness instructors and tailor-made for the participants. 4 personal training sessions will be assigned (once per week, 45 to 60 minutes per session).

Walking exercise

Behavioral

Two interventions will be provided: A) Walk-focused intervention, B) Disease-related walk intervention for participants with chronic diseases.

Slow sports and exercise

Behavioral

Participants will receive 10 training sessions (once or twice per week, 2 hours per session) conducted by professional fitness instructors. The training programs can be selected according to the participants' preference, including water exercises, stretching/fitness/gymnastics, slow walking/jogging, sports massage, Tai Chi, Yoga, etc.

Football

Behavioral

The Football Training Programme will be arranged (10 training sessions+1 game day per stage, 4 stages per season). held on artificial turf football pitch or indoor sport facilities in 5 regions

Primary outcomes

  1. Health status self-rated score

    Time frame: Changes from baseline to 3 month and 6 month post-intervention

    Measure by EQ05D-5L (range -0.59-1.0), higher score better quality of life

  2. Mobility limitation score

    Time frame: Changes from baseline to 3 month and 6 month post-intervention.

    Measured by Short Physical Performance Battery (range 0-12), higher score better physical performance

  3. Activity level

    Time frame: Changes from baseline to 3 month and 6 month post-intervention

    Measured by International Physical Activity Questionnaire.

  4. Functional mobility score

    Time frame: Changes from baseline to 3 month and 6 month post-intervention

    Score measured by Life Space Assessment questionnaire (range: 0-120), higher score better performance

  5. Sarcopenia risk score

    Time frame: Changes from baseline to 3 month and 6 month post-intervention

    Measured by Sarcopenia(SARC) questionnaire and calf circumference in unit of cm (range0-20), higher score higher risk of sarcopenia

  6. Hand grip strength

    Time frame: Changes from baseline to 3 month and 6 month post-intervention

    Hand grip strength measured by hand-held dynamometer in unit of KG

  7. Loneliness score

    Time frame: Changes from baseline to 3 month and 6 month post-intervention

    Measured by UCLA Loneliness Scale questionnaire (range20-80), higher score greater loneliness

  8. Cognitive function score

    Time frame: Changes from baseline to 3 month and 6 month post-intervention

    Measured by Montreal Cognitive Assessment (range 0-30), A score of 26 or over is considered to be normal.

Study contacts

Contact information is provided by the study sponsor or research team.

Doris Sau Fung YU, PhD

CONTACT

[email protected]

852 3817 6319

Sponsors and collaborators

Lead sponsor

The University of Hong Kong

Other

Registry information

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Oct 19, 2023
Registry last updated
Jan 8, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.